Stockler MR - Search Results

1

Survival and cardiac toxicity in patients with HER2-positive, metastatic breast cancer treated with trastuzumab in routine clinical practice.

Vasista A, Ryan L, Naher S, Moylan E, Stockler MR, Wilcken N, Kiely BE. Vasista A, et al. Among authors: stockler mr. Asia Pac J Clin Oncol. 2020 Feb;16(1):34-38. doi: 10.1111/ajco.13280. Epub 2019 Oct 28. Asia Pac J Clin Oncol. 2020. PMID: 31657878

2

Chemotherapy for metastatic breast cancer--when is enough enough?

Stockler M, Wilcken N, Coates A. Stockler M, et al. Eur J Cancer. 1997 Nov;33(13):2147-8. doi: 10.1016/s0959-8049(97)00257-8. Eur J Cancer. 1997. PMID: 9470799 No abstract available.

3

Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer.

Stockler M, Wilcken NR, Ghersi D, Simes RJ. Stockler M, et al. Cancer Treat Rev. 2000 Jun;26(3):151-68. doi: 10.1053/ctrv.1999.0161. Cancer Treat Rev. 2000. PMID: 10814559 Review.

4

Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile.

Duric V, Stockler M. Duric V, et al. Lancet Oncol. 2001 Nov;2(11):691-7. doi: 10.1016/S1470-2045(01)00559-9. Lancet Oncol. 2001. PMID: 11902540 Review.

5

Fulvestrant: spreading the word, but not too thinly.

Wilcken NR, Stockler MR. Wilcken NR, et al. Among authors: stockler mr. Lancet. 2003 Oct 18;362(9392):1254. doi: 10.1016/S0140-6736(03)14616-8. Lancet. 2003. PMID: 14575967 No abstract available.

6

Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer.

Nowak AK, Wilcken NR, Stockler MR, Hamilton A, Ghersi D. Nowak AK, et al. Among authors: stockler mr. Lancet Oncol. 2004 Jun;5(6):372-80. doi: 10.1016/S1470-2045(04)01494-9. Lancet Oncol. 2004. PMID: 15172358 Review.

7

What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?

Thewes B, Meiser B, Duric VM, Stockler MR, Taylor A, Stuart-Harris R, Links M, Wilcken N, McLachlan SA, Phillips KA, Beith J, Boyle F, Friedlander ML. Thewes B, et al. Among authors: stockler mr. Lancet Oncol. 2005 Aug;6(8):581-8. doi: 10.1016/S1470-2045(05)70254-0. Lancet Oncol. 2005. PMID: 16054569 Clinical Trial.

8

Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?

Duric VM, Stockler MR, Heritier S, Boyle F, Beith J, Sullivan A, Wilcken N, Coates AS, Simes RJ. Duric VM, et al. Among authors: stockler mr. Ann Oncol. 2005 Nov;16(11):1786-94. doi: 10.1093/annonc/mdi370. Epub 2005 Aug 26. Ann Oncol. 2005. PMID: 16126738 Free article. Clinical Trial.

9

Patients' preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile?

Duric VM, Fallowfield LJ, Saunders C, Houghton J, Coates AS, Stockler MR. Duric VM, et al. Among authors: stockler mr. Br J Cancer. 2005 Dec 12;93(12):1319-23. doi: 10.1038/sj.bjc.6602874. Br J Cancer. 2005. PMID: 16333242 Free PMC article.

10

Second consensus on medical treatment of metastatic breast cancer.

Beslija S, Bonneterre J, Burstein H, Cocquyt V, Gnant M, Goodwin P, Heinemann V, Jassem J, Köstler WJ, Krainer M, Menard S, Petit T, Petruzelka L, Possinger K, Schmid P, Stadtmauer E, Stockler M, Van Belle S, Vogel C, Wilcken N, Wiltschke C, Zielinski CC, Zwierzina H. Beslija S, et al. Ann Oncol. 2007 Feb;18(2):215-25. doi: 10.1093/annonc/mdl155. Epub 2006 Jul 10. Ann Oncol. 2007. PMID: 16831851 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

304 results

Search Page

Filters